Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Ischaemic heart disease (IHD) is the leading cause of death worldwide. The World Health Organisation (WHO) collects mortality data coded using the International Statistical Classification of Diseases (ICD) code. METHODS: We analysed IHD deaths world-wide between 1995 and 2009 and used the UN population database to calculate age-specific and directly and indirectly age-standardised IHD mortality rates by country and region. RESULTS: IHD is the single largest cause of death worldwide, causing 7,249,000 deaths in 2008, 12.7% of total global mortality. There is more than 20-fold variation in IHD mortality rates between countries. Highest IHD mortality rates are in Eastern Europe and Central Asian countries; lowest rates in high income countries. For the working-age population, IHD mortality rates are markedly higher in low-and-middle income countries than in high income countries. Over the last 25 years, age-standardised IHD mortality has fallen by more than half in high income countries, but the trend is flat or increasing in some low-and-middle income countries. Low-and-middle income countries now account for more than 80% of global IHD deaths. CONCLUSIONS: The global burden of IHD deaths has shifted to low-and-middle income countries as lifestyles approach those of high income countries. In high income countries, population ageing maintains IHD as the leading cause of death. Nevertheless, the progressive decline in age-standardised IHD mortality in high income countries shows that increasing IHD mortality is not inevitable. The 20-fold mortality difference between countries, and the temporal trends, may hold vital clues for handling IHD epidemic which is migratory, and still burgeoning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“Firstly, policy changes may favour risk factor modi fi cation, such as decreased exposure to tobacco smoke [21] and improvement in primary prevention strategies [22,23] (e.g. hypertension control [24 – 26]).”
BackgroundMACMAHON, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90878-9 · Cited by 4,253 · cited 1×
“hypertension control [24–26]).”
Writing Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
Priority actions for the non-communicable disease crisis
Beaglehole, R., Bonita, R., Horton, R., Adams, C., Alleyne, G., Asaria, P., Baugh, V., Bekedam, H., Billo, N., Casswell, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60393-0 · Cited by 1,615 · cited 1×
“For example generic aspirin and statins are available cheaply, and government initiatives to reduce smoking need not be fi nancially demanding [41].”
BackgroundSelf-citationThe burden and costs of chronic diseases in low-income and middle-income countries.
Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M., & Strong, K. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61696-1 · Cited by 1,603 · cited 1×
“IHD contributes substantially to premature mortality in these populations, and reducing IHD mortality will increase the lifespan of working-age populations, and may therefore have an important effect on economic growth [40].”
BackgroundEuropean cardiovascular disease statistics
Allender, S. E., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R., & Gray, A. M. (2008) · Deakin Research Online (Deakin University) · Cited by 1,459
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Cited by
Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P., & Al-Lamee, R. (2019) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005375 · Cited by 860
Self-citationKeene, D., Price, C., Shun-Shin, M. J., & Francis, D. P. (2014) · BMJ · doi:10.1136/bmj.g4379 · Cited by 513
Self-citationYang, H., Wang, C., Liu, C., Chen, H., Wu, Y., Han, J., Jia, Z., Lin, W., Zhang, D., Li, W., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.022 · Cited by 399
Cancer as a disease of old age: changing mutational and microenvironmental landscapes
Laconi, E., Marongiu, F., & DeGregori, J. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0721-1 · Cited by 348
Christiansen, M. N., Køber, L., Weeke, P., Vasan, R. S., Jeppesen, J. L., Smith, J. G., Gislason, G. H., Torp-Pedersen, C., & Andersson, C. (2017) · Circulation · doi:10.1161/circulationaha.116.025941 · Cited by 286
Safiri, S., Karamzad, N., Singh, K., Carson-Chahhoud, K., Adams, C., Nejadghaderi, S. A., Almasi-Hashiani, A., Sullman, M. J. M., Mansournia, M. A., Bragazzi, N. L., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab213 · Cited by 282
The Role of Autophagy in Vascular Biology
Nussenzweig, S. C., Verma, S., & Finkel, T. (2015) · Circulation Research · doi:10.1161/circresaha.116.303805 · Cited by 244
“age remains the single largest risk factor for cardiovascular disease.(84) This also suggests that pharmacological strategies”
BackgroundInhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation
Tang, J., Lobatto, M. E., Hassing, L., van der Staay, S., van Rijs, S. M., Calcagno, C., Braza, M. S., Baxter, S., Fay, F., Sanchez-Gaytan, B. L., et al. (2015) · Science Advances · doi:10.1126/sciadv.1400223 · Cited by 226
Zhou, S.-F., Cheng, J., Zhou, Z.-W., Sheng, H.-P., He, L.-J., Fan, X.-W., He, Z.-X., Sun, T., Zhang, X., Gu, L., et al. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s72892 · Cited by 213
“61 From 2006 to 2010, age-adjusted ischemic heart disease prevalence in the US declined overall from 6.7% to 6.0%.”
InfluentialZhao, J., Stockwell, T., Roemer, A., Naimi, T., & Chikritzhs, T. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.375 · Cited by 173
“CHD affects individuals of all ages, men more so than women (Finegold et al., 2013).”
BackgroundHollings, M., Mavros, Y., Freeston, J., & Fiatarone Singh, M. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317713329 · Cited by 148
“are dropping, the actual burden of CHD is growing due to an increased prevalence with age(3) and the aging population of developed countries.(4,5) Thus, with both higher prevalence and survival rates, there is a need to improve secondary and tertiary prevention programs to limit recurrent events, improve the quality o…”
BackgroundRasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125
“[4] JA Finegold, Asaria P, Francis DP.”
Recent advances to accelerate re-endothelialization for vascular stents
Bedair, T. M., ElNaggar, M. A., Joung, Y. K., & Han, D. K. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417731546 · Cited by 89
Huo, J., Xu, Z., Hosoe, K., Kubo, H., Miyahara, H., Dai, J., Mori, M., Sawashita, J., & Higuchi, K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3181759 · Cited by 87
Rasmussen, K. L., Tybjærg-Hansen, A., Nordestgaard, B. G., & Frikke-Schmidt, R. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz402 · Cited by 86
Sekikawa, A., Miyamoto, Y., Miura, K., Nishimura, K., Willcox, B. J., Masaki, K. H., Rodriguez, B., Tracy, R. P., Okamura, T., & Kuller, L. H. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv143 · Cited by 44
Chauvierre, C., Aid-Launais, R., Aerts, J., Chaubet, F., Maire, M., Chollet, L., Rolland, L., Bonafé, R., Rossi, S., Bussi, S., et al. (2019) · Marine Drugs · doi:10.3390/md17120699 · Cited by 43
“disorders such as diabetes and obesity [1].”
Role of sGC-dependent NO signalling and myocardial infarction risk
Wobst, J., Kessler, T., Dang, T. A., Erdmann, J., & Schunkert, H. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1265-3 · Cited by 28
Mayne, J., Ooi, T. C., Tepliakova, L., Seebun, D., Walker, K., Mohottalage, D., Ning, Z., Abujrad, H., Mbikay, M., Wassef, H., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00777 · Cited by 24
Wang, Y., Wang, Y., Adi, D., He, X., Liu, F., Abudesimu, A., Fu, Z., & Ma, Y. (2020) · Medicine · doi:10.1097/md.0000000000020924 · Cited by 6
“7% of global mortality.([2]) Several risk factors,”
Metadata
- Authors
- Finegold, J. A., Asaria, P., & Francis, D. P.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 168
- Issue
- 2
- Pages
- 934-945
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W2020703194
- Cited by
- 860
- References
- 39
- FWCI
- 31.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.